Skip to content
Open access

FAP+ pericyte-like cells promote monocyte differentiation into tumor-associated macrophages in glioblastoma

Sep 2026 · Experimental and Molecular Medicine · Vol 58, pp. 3177 - 3195 · 0 citations · 76 references
Medicine

TL;DR

It is found that FAP+ pericytes are linked to increased monocyte recruitment and differentiation into tumor-associated macrophages, particularly those with an M2-like, tumor-supportive phenotype, and Targeting this stromal population may offer new therapeutic avenues to reprogram tumor-associated immune responses in GBM.

Abstract

Glioblastoma (GBM) is a highly aggressive primary brain tumor characterized by profound immunosuppression that facilitates tumor progression and promotes therapeutic resistance. Fibroblast activation protein (FAP), a recognized theranostic target in multiple cancers, is upregulated in GBM and predominantly expressed by pericyte-like stromal cells. Here we identify a role for FAP⁺ pericyte-like cells in shaping the GBM immune microenvironment through monocyte recruitment and differentiation. Analysis of The Cancer Genome Atlas (TCGA) datasets, supported by reverse-transcription quantitative PCR and immunohistochemistry, revealed that elevated FAP expression—serving as a proxy for the abundance of FAP⁺ pericyte-like cells—is associated with an immune-enriched tumor microenvironment characterized by higher macrophage abundance and elevated expression of M2 polarization markers. Spatial analyses, including immunofluorescence and spatial transcriptomics, demonstrated that immunosuppressive macrophages preferentially localize in proximity to FAP⁺ pericytes. Single-cell RNA sequencing identified these FAP⁺ cells as a distinct perivascular stromal subset with a unique expression pattern of extracellular matrix components and cytokines, including CCL2 and CSF1, with corresponding receptors expressed on myeloid cells. Functional assays using patient-derived FAP⁺ pericyte-like cells confirmed their ability to attract monocytes via soluble mediators and to promote their differentiation and polarization into tumor-associated macrophages with immunoregulatory features, partly mediated by the CSF1–CSF1R axis. Orthotopic co-implantation experiments in mice further supported their capacity to enhance myeloid infiltration in vivo. Consistent with these biological effects, a transcriptional signature characteristic of FAP⁺ pericytes correlated with worse overall survival in patients with GBM. Together, these findings position FAP⁺ pericyte-like cells as modulators of the GBM immune landscape, fostering a tumor-permissive niche by promoting the differentiation of circulating monocytes into immunoregulatory macrophages. Targeting this stromal population may offer new therapeutic avenues to reprogram tumor-associated immune responses in GBM. Glioblastomas (GBMs), aggressive brain tumors, are marked by a complex microenvironment with diverse immune cells, including tumor-associated macrophages. This study explores the role of fibroblast activation protein (FAP)-positive pericyte-like cells in shaping the immune landscape of GBM. Using data from The Cancer Genome Atlas, single-cell RNA sequencing and spatial transcriptomics, the authors found that FAP+ pericytes are linked to increased monocyte recruitment and differentiation into tumor-associated macrophages, particularly those with an M2-like, tumor-supportive phenotype. These cells express high levels of chemokines such as CCL2 and CSF1, which are crucial for monocyte attraction and macrophage polarization. The study suggests that FAP+ pericytes contribute to the immunosuppressive environment in GBMs, potentially impacting patient survival. Future research could explore targeting these pericytes to modulate the tumor microenvironment and improve therapeutic outcomes. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.

Read PDF

Similar papers

Open access Aug 2026

POSTN⁺ CAF–SPP1⁺ macrophage crosstalk is associated with immune exclusion and poor prognosis in lung adenocarcinoma

A spatially organized POSTN⁺ CAF–SPP1⁺ macrophage niche that may contribute to stromal remodeling, CD8⁺ T-cell exclusion, and potentially reduced immunotherapy benefit in LUAD is defined.

Ankang Zhu, Jian-Yuan Huang, Juan Zhang et al. · 0 citations
Open access Aug 2026

PDCD10-Deficient Tumor Cells Reprogram Angiogenesis Through Paracrine Endothelial Activation and GSC-like Plasticity in GBM

It is demonstrated that PDCD10 loss promotes GBM neo-angiogenesis involving complementary paracrine and GSC-like plasticity mechanisms, highlighting PDCD10 as a potential therapeutic target to suppress neo-angiogenesis in GBM.

Zhong-Rong Chen, Zhen Chen, Xue Wan et al. · 0 citations
Open access Sep 2026

DEFB1 + Cancer Cell-IFI30+ Macrophage Crosstalk Drives Immunosuppressive Niche in Intrahepatic Cholangiocarcinoma.

Intrahepatic cholangiocarcinoma (ICC) is a rare but highly aggressive primary liver malignancy distinguished by a profoundly heterogeneous tumor microenvironment, which underlies its limited response to targeted and immune-based therapies. Deciphering the cellular composition and intercellular signaling within this com...

Guo-Liang Wang, Hang Meng, Meng Li et al. · 0 citations
Sep 2026

Vascularized glioblastoma-on-a-chip reveals microglia-mediated regulation of tumor invasion and stemness.

Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor in adults, characterized by rapid progression and poor prognosis. Central to GBM pathobiology are glioma stem cells (GSCs), which preferentially localize within the perivascular niche (PVN) and sustain tumor growth, invasion, and therapeutic resis...

Twinkle Jina Minette Manoharan, K. Ravi, Shwetal Mehta et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.